LoginRegister
    Illegal renting of licences to Chemists: 241 Gujarat Pharmacists lose RegistrationIllegal renting of licences to Chemists: 241 Gujarat Pharmacists lose Registration
    USFDA rebukes Torrent Pharma management of inadequacy, violations at multiple sitesUSFDA rebukes Torrent Pharma management of inadequacy, violations at multiple sites
    Mylan moves application with DCGI to launch new TB drug Pretomanid in IndiaMylan moves application with DCGI to launch new TB drug Pretomanid in India
    JnJ cancer drugs Darzalex, Imbruvica help it beat profit estimates for third-quarterJnJ cancer drugs Darzalex, Imbruvica help it beat profit estimates for third-quarter
    Sanofi opens digital biologics manufacturing facility in USSanofi opens digital biologics manufacturing facility in US
    Abbott, Tandem Diabetes Care explore integrated solutions to improve diabetes managementAbbott, Tandem Diabetes Care explore integrated solutions to improve diabetes management
    Judge admits making USD 107 million miscalculation in Johnson and Johnson opioid caseJudge admits making USD 107 million miscalculation in Johnson and Johnson opioid case
    Healthcare sector adversely impacted due to NPPA regulatory measures: ICRAHealthcare sector adversely impacted due to NPPA regulatory measures: ICRA
    Granules India to exit from Chinese JV Granules BiocauseGranules India to exit from Chinese JV Granules Biocause
    AstraZeneca, Pfizer, Takeda Pharma ink agreement with ImaginAb to develop tumour imaging technologyAstraZeneca, Pfizer, Takeda Pharma ink agreement with ImaginAb to develop tumour imaging technology
    Allergan shareholders okays USD 63 billion AbbVie acquisitionAllergan shareholders okays USD 63 billion AbbVie acquisition
    Roche Rituximab shows positive data in rare skin disease Pemphigus VulgarisRoche Rituximab shows positive data in rare skin disease Pemphigus Vulgaris
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X